Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TapRoot is a private digital health company based in Phoenix, Arizona, focused on improving care for people living with dementia and other neurocognitive disorders. Its core product, Ella®, is an AI-enabled, HIPAA-compliant personalized care management and caregiver support platform that recommends person-centered, non-pharmacological interventions to help prevent or de-escalate behavioral episodes. The company primarily sells into senior living, memory care, long-term care, and home care settings, where Ella is used to support caregivers, training, quality measurement, and value-based care workflows. TapRoot has announced pilots and commercial deployments with senior care operators and integrations with health IT partners such as Medtelligent. The business is best characterized as a commercial-stage healthcare IT and behavioral health technology company rather than a therapeutics developer.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TapRoot Interventions & Solutions.